SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

被引：0
|
作者：
Yehong Bin
Dong Lan
Wenguang Bao
Haiyan Yang
Shengsheng Zhou
Fengxiang Huang
Man Wang
Zhigang Peng
机构：
[1] the First Affiliated Hospital of Guangxi Medical University,Department of Oncology
来源：
Trials | / 23卷
关键词：
Advanced gastric cancer; Malignant ascites; Intraperitoneal infusion of chemotherapy; First-line chemotherapy; Docetaxel; S-1; Oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer
    Zhong, Dong-ta
    Wu, Ri-ping
    Wang, Xin-li
    Huang, Xiao-bing
    Lin, Meng-xin
    Lan, Yan-qin
    Chen, Qiang
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 867 - 873
  • [32] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
    Kazuaki Tanabe
    Takahisa Suzuki
    Noriaki Tokumoto
    Hideki Yamamoto
    Kazuhiro Yoshida
    Hideki Ohdan
    World Journal of Surgical Oncology, 8
  • [33] An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
    Chu, Yunqian
    He, Xuan
    Xue, Ya
    Jiang, Hua
    Zhu, Chan
    Qi, Chunjian
    Zhang, Xing
    Chen, Dongsheng
    Dai, Hanjue
    Xian, Qingying
    Zhu, Wenyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [34] XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX)
    Xiao-Dong Zhu
    Ming-Zhu Huang
    Yu-Sheng Wang
    Wan-Jing Feng
    Zhi-Yu Chen
    Yi-Fu He
    Xiao-Wei Zhang
    Liu, Xin
    Chen-Chen Wang
    Zhang, Wen
    Jie-Er Ying
    Wu, Jun
    Yang, Lei
    Yan-Ru Qin
    Jian-Feng Luo
    Xiao-Ying Zhao
    Wen-Hua Li
    Zhang, Zhe
    Li-Xin Qiu
    Qi-Rong Geng
    Jian-Ling Zou
    Jie-Yun Zhang
    Zheng, Hong
    Xue-Feng Song
    Shu-Sheng Wu
    Cheng-Yan Zhang
    Gong, Zhe
    Qin-Qin Liu
    Xiao-Feng Wang
    Xu, Qi
    Wang, Qi
    Jian-Mei Ji
    Zhao, Jian
    Wei-Jian Guo
    CANCER COMMUNICATIONS, 2022, 42 (04) : 314 - 326
  • [35] Docetaxel and Oxaliplatin as First-Line Therapy for Advanced Non-Small Cell Lung Cancer: A Phase II Trial
    Radhakrishnan, A.
    Bitran, J. D.
    Milton, D. T.
    Tolzien, K.
    Hallmeyer, S.
    Nabhan, C.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (04) : 439 - 444
  • [36] A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Chen, Jen-Shi
    Chen, Yen-Yang
    Huang, Jen-Sheng
    Yeh, Kun-Yun
    Chen, Ping-Tsung
    Shen, Wen-Chi
    Hsu, Hung-Chih
    Lin, Yung-Chung
    Wang, Hung-Ming
    GASTRIC CANCER, 2012, 15 (01) : 49 - 55
  • [37] A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
    Herzog, Thomas J.
    Monk, Bradley J.
    Rose, Peter G.
    Braly, Patricia
    Hines, Jeffrey F.
    Bell, Maria C.
    Wenham, Robert M.
    Secord, Angeles Alvarez
    Roman, Lynda D.
    Einstein, Mark H.
    Drake, Richard D.
    Childs, Barrett H.
    GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 517 - 525
  • [38] A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Jen-Shi Chen
    Yen-Yang Chen
    Jen-Sheng Huang
    Kun-Yun Yeh
    Ping-Tsung Chen
    Wen-Chi Shen
    Hung-Chih Hsu
    Yung-Chung Lin
    Hung-Ming Wang
    Gastric Cancer, 2012, 15 : 49 - 55
  • [39] Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake
    Osumi, Hiroki
    Takahari, Daisuke
    Chin, Keisho
    Ogura, Mariko
    Ichimura, Takashi
    Wakatsuki, Takeru
    Suzuki, Takeshi
    Ota, Yumiko
    Nakayama, Izuma
    Ooki, Akira
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Yamaguchi, Kensei
    ONCOTARGETS AND THERAPY, 2018, 11 : 8301 - 8307
  • [40] Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
    Changhoon Yoo
    Min-Hee Ryu
    Young-Soon Na
    Baek-Yeol Ryoo
    Chae-Won Lee
    Jeheon Maeng
    Se-Yeon Kim
    Dong Hoe Koo
    Inkeun Park
    Yoon-Koo Kang
    Investigational New Drugs, 2014, 32 : 271 - 278
12345